375 related articles for article (PubMed ID: 8084431)
21. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
22. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
[TBL] [Abstract][Full Text] [Related]
23. Assessments of pulmonary involvement in patients with systemic sclerosis.
Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
[TBL] [Abstract][Full Text] [Related]
24. [Pulmonary involvement in scleroderma assessed with high-resolution computerized tomography and functional tests].
Dellafiore L; Colombo B; Del Sante M; Farina D; Zanoni C; Amaducci S; Beulcke G
Radiol Med; 1994 May; 87(5):608-13. PubMed ID: 8008890
[TBL] [Abstract][Full Text] [Related]
25. Cranial nerve VIII involvement in a patient with progressive systemic sclerosis.
Iskandar SB; Loyd S; Roy TM
Tenn Med; 2004 Mar; 97(3):117-9. PubMed ID: 15054944
[TBL] [Abstract][Full Text] [Related]
26. Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.
Edelson JD; Hyland RH; Ramsden M; Chamberlain DW; Kortan P; Meindok HO; Klein MH; Braude AC; Lee P; Rebuck AS
J Rheumatol; 1985 Oct; 12(5):957-63. PubMed ID: 4087272
[TBL] [Abstract][Full Text] [Related]
27. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
29. Renal involvement in scleroderma.
Desai Y; Ghanekar MA; Siquera RD; Joshi VR
J Assoc Physicians India; 1990 Oct; 38(10):768-70. PubMed ID: 2084079
[TBL] [Abstract][Full Text] [Related]
30. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of DLco for the early diagnosis of pulmonary involvement in collagen diseases].
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Apr; 31(4):480-5. PubMed ID: 8515621
[TBL] [Abstract][Full Text] [Related]
32. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Abnormalities on High-Resolution Computerized Tomography, Pulmonary Function, and Bronchoalveolar Lavage in Progressive Systemic Sclerosis.
Cakmak G; Selcuk Can T; Gundogdu S; Akman C; Ikitimur H; Musellim B; Ongen G
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):349-354. PubMed ID: 28079847
[TBL] [Abstract][Full Text] [Related]
34. [Pulmonary alveolar proteinosis].
Briens E; Delaval P; Mairesse MP; Valeyre D; Wallaert B; Lazor R; Cordier JF;
Rev Mal Respir; 2002 Apr; 19(2 Pt1):166-82. PubMed ID: 12040317
[TBL] [Abstract][Full Text] [Related]
35. [Cardiac and pulmonary involvement in scleroderma].
Launay D; Hachulla E
Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary changes in progressive systemic sclerosis].
Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
[TBL] [Abstract][Full Text] [Related]
37. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
Giordano M; Ara M; Capelli L; Tirri G; Vatti M
Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
39. [Contemporaneous clinical picture of systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):416-20. PubMed ID: 20568410
[TBL] [Abstract][Full Text] [Related]
40. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
